Margaret Harbison
Psychiatry · Marlton, NJNPI 1245357235
Payments from drug & device makers
Across 182 payments — averaging $15.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$322
- Lundbeck LLC$278
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$244
- Corium, LLC$241
- Vanda Pharmaceuticals Inc.$229
- Otsuka America Pharmaceutical, Inc.$216
- plus $1K from 18 others
What the payments were for
- Food & beverage$2,68098%
- Education$512%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 25 | $322 |
| Lundbeck LLC | 18 | $278 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $244 |
| Corium, LLC | 17 | $241 |
| Vanda Pharmaceuticals Inc. | 16 | $229 |
| Otsuka America Pharmaceutical, Inc. | 13 | $216 |
| Bausch Health US, LLC | 13 | $193 |
| Sunovion Pharmaceuticals Inc. | 13 | $171 |
| Tris Pharma Inc | 9 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $124 |
| Axsome Therapeutics, Inc. | 6 | $102 |
| Alkermes, Inc. | 5 | $75 |
| Ironshore Pharmaceuticals Inc. | 5 | $69 |
| Neurocrine Biosciences, Inc. | 4 | $58 |
| Collegium Pharmaceutical, Inc. | 3 | $55 |
| Idorsia Pharmaceuticals US Inc | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Vertical Pharmaceuticals, LLC | 2 | $29 |
| Johnson & Johnson | 2 | $28 |
| Almatica Pharma LLC | 2 | $27 |
| Harmony Biosciences LLC | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Alfasigma USA, Inc. | 1 | $13 |
| Neuronetics, Inc. | 1 | $9 |
How this compares
$2,731 in reported general payments places this provider in the 85th percentile of 1,119 psychiatry providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 22 | $29,311 |
| ClozarilClozapine | 23 | $19,017 |
| RisperdalRisperidone | 11 | $12,613 |
| Lurasidone Hcl | 14 | $4,747 |
| VyvanseLisdexamfetamine Dimesylate | 11 | $4,176 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 25 | $1,881 |
| Bupropion XlBupropion Hcl | 59 | $1,581 |
| Mirtazapine | 57 | $1,102 |
| Escitalopram Oxalate | 78 | $1,003 |
| Paroxetine CrParoxetine Hcl | 26 | $892 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 24 | $828 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 37 | $819 |
| Quetiapine Fumarate | 20 | $560 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 22 | $504 |
| Buspirone Hcl | 29 | $484 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $216 | $29,31122 claims |
| Johnson & JohnsonRisperdal | $28 | $12,61311 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $124 | $4,17611 claims |
| Almatica Pharma LLCSertraline Hcl | $27 | $17634 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,119 psychiatry providers in New Jersey.
Other psychiatry in Marlton
- Lloyd AlceraMarlton$187K
- Jake RosenbergMarlton$80K
- Leon RosenbergCherry Hill$6.4M
- Steven GlassClementon$3.9M
- Judith JosephPaterson$3.8M
- Jeffrey ApterPrinceton$1.7M
- Roberta BallCherry Hill$741K
- Marc CantillonLivingston$524K
- Sanjay VarmaPrinceton$479K
- Manuel SanchezNewark$474K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.